Comments
Loading...

Vaxxinity

VAXXOTCEM
Logo brought to you by Benzinga Data
$0.00050
0.00010025.00%
At close: -
Consensus Rating1
Outperform
Highest Price Target1
$7.00
Lowest Price Target1
$7.00
Consensus Price Target1
$7.00

Vaxxinity (OTC:VAXX) Stock, Analyst Ratings, Price Targets, Forecasts

Vaxxinity Inc has a consensus price target of $7 based on the ratings of 2 analysts. The high is $7 issued by Baird on September 8, 2023. The low is $7 issued by Baird on September 8, 2023. The 1 most-recent analyst ratings were released by Baird on September 8, 2023, respectively. With an average price target of $7 between Baird, there's an implied 1399900.00% upside for Vaxxinity Inc from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
4.7
Strong Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Baird

1calculated from analyst ratings

Analyst Ratings for Vaxxinity

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Vaxxinity (VAXX) stock?

A

The latest price target for Vaxxinity (OTCEM:VAXX) was reported by Baird on September 8, 2023. The analyst firm set a price target for $7.00 expecting VAXX to rise to within 12 months (a possible 1399900.00% upside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Vaxxinity (VAXX)?

A

The latest analyst rating for Vaxxinity (OTCEM:VAXX) was provided by Baird, and Vaxxinity initiated their outperform rating.

Q

When was the last upgrade for Vaxxinity (VAXX)?

A

There is no last upgrade for Vaxxinity

Q

When was the last downgrade for Vaxxinity (VAXX)?

A

There is no last downgrade for Vaxxinity.

Q

When is the next analyst rating going to be posted or updated for Vaxxinity (VAXX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaxxinity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaxxinity was filed on September 8, 2023 so you should expect the next rating to be made available sometime around September 8, 2024.

Q

Is the Analyst Rating Vaxxinity (VAXX) correct?

A

While ratings are subjective and will change, the latest Vaxxinity (VAXX) rating was a initiated with a price target of $0.00 to $7.00. The current price Vaxxinity (VAXX) is trading at is $0.00, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.